Skip to main content
Fig. 2 | BMC Medicine

Fig. 2

From: Effect of intravenous urokinase vs best medicine treatment on functional outcome for patients with acute minor stroke (TRUST): a randomized controlled trial

Fig. 2

Distribution of modified Rankin scale (mRS) scores at 90 days in the intention-to-treat population. The mRS scores ranged from 0 to 6: 0, no symptoms; 1, symptom without clinically significant disability; 2, slight disability; 3, moderate disability; 4, moderately severe disability; 5, severe disability; and 6, death

Back to article page